4-(6-Fluorobenzo[d]isoxazol-3-yl)-1-[2-(9-hydroxy-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl)ethyl]piperidine-1-oxide PurCert Secondary Reference Standard (CRM) [Includes all characterization data]
CRM
Synonym: Paliperidone N-Oxide
Linear Formula:
C23H27FN4O4
Molecular Weight: 442.48 g/mol
CAS Number: 761460-08-6
Properties
| Assay Purity | >=98% |
| B pt. | NA |
| M pt. | 160-162 °C |
| Form | Solid |
Safety Information
| Hazard Statement(s) | H301 |
| Precautionary Statement | P264 - P270 - P301 + P310 - P405 - P501 |
| GHS Pictogram |
|
| Signal word | Danger |
| HS Code | 29349990 |
| Storage Temp. | 2-8°C |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| UN Number | 2811 |
Description
Application
Used mainly in pharmaceutical research and drug development. Serves as an advanced synthetic intermediate for biologically active molecules. Investigated for potential central nervous system (CNS) or therapeutic applications. Applied in structureactivity relationship (SAR) studies in medicinal chemistry.
Purpose
The primary purpose of this compound is to function as a research and pharmaceutical intermediate in the development of new drug candidates. Its multiple heterocyclic and functional groups are designed to improve biological activity selectivity and solu
General Description
This is a complex heterocyclic organic compound containing- a fluorobenzisoxazole ring a piperidine N-oxide group and a pyridopyrimidinone moiety. Such structures are commonly studied in medicinal chemistry because they can interact with biological receptors and enzymes.
Documents
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form | |
| Sample COA |